BPC 157 (Extra) Beligas
| Features | |
| Active substance | BPC-157 Pentadecapeptide |
| Also known as | Body Protection Compound-157 |
| Blood pressure | No significant effects reported |
| Chemical name | Glycyl-L-О±-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-О±-aspartyl-L-О±-aspartyl-L-alanyl-L-glycyl-L-leucyl-L-valyl |
| Dosage (medical) | 250-1000 mcg/day |
| Dosage (sports) | 200-800 mcg/day |
| Effects | Promotes healing of various tissue types, including muscle, tendon, and ligament injuries |
| Formula | C62H98N16O22 |
| Half-life | Variable (hours to days, depending on administration route) |
| Hepatotoxicity | None reported |
| Lab Test | Specific assays for BPC-157 detection not widely available |
| Main action | Tissue healing and regeneration |
| Side effects | Very few reported, potential mild gastrointestinal disturbances |
| Storage conditions | Store in a cool, dry place away from light, typically refrigerated |
| Substance class | Peptide |
| Trade name | Not commercially available under a specific trade name |
| Use in sports | Recovery from injuries, enhanced healing |
| WAREHOUSE | International Warehouse 3 |
| Water Retention | Minimal |
| Manufacturer | Beligas |